TORONTO, ONTARIO — (Marketwired) — 08/17/17 — The common shares of CannTrust Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at .
CannTrust, since its inception in 2014, has led the Canadian market in producing pharmaceutically standardized product. As a federally regulated licensed producer, CannTrust brings more than 40 years of pharmacy and healthcare experience to the medical cannabis industry. CannTrust currently operates a 50,000 square foot state-of-the-art hydroponic facility in Vaughan, Ontario and is upgrading a 430,000 square foot cultivation facility in the Niagara region.
L–inscription a la cote de CSE des actions ordinaires de CannTrust Holdings Inc. a ete approuvee.
Les documents d–inscription et de divulgation seront disponibles sur .
CannTrust, depuis sa creation en 2014, a conduit le marche canadien a produire des produits pharmaceutiquement standardises. En tant que producteur agree sous reglementation federale, CannTrust apporte plus de 40 ans d–experience en pharmacie et en soins de sante a l–industrie medicale du cannabis. CannTrust exploite actuellement une installation hydroponique a la fine pointe de la technologie de 50 000 pieds carres a Vaughan, en Ontario, et met a niveau une installation de culture de 430 000 pieds carres dans la region de Niagara.
Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340